Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 24
Filtre
1.
Rev. Hosp. Clin. Univ. Chile ; 32(1): 4-16, 2021. tab, ilus, graf
Article Dans Espagnol | LILACS | ID: biblio-1252505

Résumé

Platelet rich plasma (PRP) is used to speed up tissue repair. Despite its widespread use, the therapeutic application of PRP generates controversies in clinical results due to the variability in methods of obtaining the different preparations and differences between the components of different types of PRP, so it's recommended to mention the type of platelet preparation used. In this article, we describe technical and biologics characteristics of our platelet product, and we compare them to different commercial preparations described in order to validate their clinical use. Our results determine that the preparation can be considered a platelet rich plasma with biological activity in vivo and in vitro, which supports its use as a valid therapeutic tool, alternative to products currently available in Regenerative Medicine. (AU)


Sujets)
Humains , Médecine régénérative/tendances , Plasma riche en plaquettes , Thérapie cellulaire et tissulaire
2.
Rev. Hosp. Clin. Univ. Chile ; 30(3): 207-217, 2019. tab, graf, ilus
Article Dans Espagnol | LILACS | ID: biblio-1051370

Résumé

V617F mutation in exon 14 of Janus Kinase 2 gene (jak-2) is used as a molecular marker for the diagnosis of Philadelphia negative myeloproliferative neoplasms (Phi-) such as Polycythemia Vera (PV), Essential Thrombocythemia (ET) and Primary Myelofibrosis (MFP). To detect this mutation, we used conventional polymerase chain reaction technique (PCR), a simple and inexpensive technique, however, has some drawbacks that current technology allows to solve. During the last years, more sensitive molecular techniques have been incorporated in clinical practice to support the diagnosis, prognosis and follow-up of hematological patients. For its implementation in the clinical routine should be considered technical and economic aspects, so in this work, we evaluate the Real Time PCR technique as a diagnostic method for the detection of the Jak-2-V617F mutation, using in house primers design. Our result show that the technique implemented has a concordance index of 0.87 with the conventional PCR used in the molecular diagnosis of myeloproliferative neoplasms. In addition, it has the same specificity, greater sensitivity and, shorter execution time in relation to conventional PCR. The implementation of this diagnostic method in our Hospital is technically possible and commercially convenient. (AU)


Sujets)
Humains , Kinase Janus-2/analyse , Réaction de polymérisation en chaine en temps réel/méthodes , Syndromes myéloprolifératifs/diagnostic , Réaction de polymérisation en chaine en temps réel/tendances
3.
Rev. med. interna Guatem ; 19(3): [10], sept.-dic. 2015. gráficos
Article Dans Espagnol | LILACS | ID: biblio-996522

Résumé

Estudio descriptivo realizado para determinar la percepción que tienen los guatemaltecos y guatemaltecas sobre la donación voluntaria de sangre. Se utilizaron tres encuestas dirigidas a tres poblaciones diferentes: personas que si donan, personas que no donan (observadoras) y personas que fueron diferidas durante la donación . De las 518 personas que acudieron a las diferentes colectas de donación voluntaria, únicamente 378 (73%) participaron en las encuestas. Se logró establecer que las personas que donan se sienten motivadas a colaborar con los que necesitan los hemoderivados. Los que fueron diferidos se mostraron decepcionados por no haber logrado pasar el proceso previo a la donación. Los observadores sentían curiosidad por el proceso pero no mostraron disposición para donar, o para aceptar la responsabilidad de que su sangre fuera transfundida...(AU)


It is a descriptive study to determine the perception Guatemalans on voluntary blood donation. If people donate , people do not donate ( observer ) and people that were deferred during the donation , three surveys of three different populations were used. Of the 518 people who attended the various collections of voluntary donation, only 378 ( 73 %) participated in the polls. It was established that people who donate are motivated to collaborate with those who need blood products. Those who were deferred were disappointed not to have made it through the pre- donation process. The observers were curious about the process but did not show willingness to donate , or to accept responsibility for his blood was transfused...(AU)


Sujets)
Humains , Mâle , Femelle , Donneurs de sang/enseignement et éducation , Donneurs de sang/ressources et distribution , Médecine transfusionnelle/méthodes , Sécurité sociale , Banques de sang , Guatemala
4.
Rev. méd. Chile ; 140(5): 555-560, mayo 2012. ilus, tab
Article Dans Espagnol | LILACS | ID: lil-648580

Résumé

Background: Minor histocompatibility antigens (mHAgs) play a critical role in the immune responses associated with allogeneic stem cell transplantation, such as graft versus host disease (GVHD) and graft-versus-tumor (GVT). Aim: To determine the gene frequencies of the mHAgs HA-1, HA-2 and HA-8 in Chilean Blood Bank donors. Material and Methods: Blood from 192 blood donors was analyzed. The presence of haplotype HLA-A*02 was determined by flow cytometry. The frequency of mHAgs was determined by allele specific polymerase chain reaction in genomic DNA. Results: Sixty one participants were carriers of the haplotype HLA-A*02. The relative allele frequency HA-1H was 45%, HA-Ir 55%, HA-2V 80.6%, HA-2M 19.4%, HA-8R 49.8% and HA-8P was 50.2%. Based on mHAgs disparity between HA-1, HA-2 or HA-8, the probability to generate a GVT response in HLA-A*02 individuals was 40%. Conclusions: The mHAgs frequency in Chilean population is under Hardy-Weinberg equilibrium and they are similar to those of other ethnic populations in the world.


Sujets)
Humains , Donneurs de sang , Fréquence d'allèle/génétique , Maladie du greffon contre l'hôte , Antigènes HLA/génétique , Antigènes mineurs d'histocompatibilité/génétique , Chili , Maladie du greffon contre l'hôte/génétique , Maladie du greffon contre l'hôte/immunologie , Réaction du greffon contre la tumeur/génétique , Test d'histocompatibilité , Antigènes mineurs d'histocompatibilité/analyse , Antigènes mineurs d'histocompatibilité/immunologie , Réaction de polymérisation en chaîne , Transplantation de cellules souches , Transplantation homologue
5.
Rev. Hosp. Clin. Univ. Chile ; 21(2): 147-153, 2010.
Article Dans Espagnol | LILACS | ID: lil-620983

Résumé

Patients who receive allo hematopoietic stem cell transplantation (SCT) could develop graft versus host disease and/or graft versus tumour effect. These immunological responses can happen even with perfect fully HLA matched haematopoietic stem cells. Moreover, the engraftment of the donor’s cells depends on the immunological conditions of both donor and recipient. The development of alloreactivity occurs in the context of the polymorphisms of the human genome, these genomic differences results in proteins with antigenic properties which trigger immune responses. Considering this, the SCT is a powerful tool to heal the patient disease, because all of them become chimeras. In other words, into individuals with two different genomic sets, which will develop a strong immunological response that cannot exist in natural conditions.


Sujets)
Humains , Mâle , Femelle , Antigènes , Histocompatibilité/immunologie , Système immunitaire/malformations , Système immunitaire/traumatismes , Système immunitaire/anatomopathologie , Immunologie en transplantation
6.
Rev. Fed. Odontol. Colomb ; 71(223): 36-41, mayo-jun. 2008.
Article Dans Espagnol | LILACS | ID: lil-541034

Résumé

Objetivo: diseñar, implementar y evaluar un programa de higiene oral para niños y jóvenes con discapacidad cognitiva, psicomotora y de lenguaje. Materiales y métodos: este estudio es cuasi-experimental y su objetivo es mejorar la higiene bucal mediante la implementación de un programa que utiiza las estrategias de musicoterapia (Minueto y Rondó del divertimento en Re efecto Mozart) y tableros de comunicación, en una población de 41 niños y jóvenes etre 3 y 28 años con discapacidad cognitiva, psicomotora y del lenguaje, de la Corporación Seres Integrales Serin. Se hizo una revisión de las deficiencias de cada uno de los niños, se diseñó el programa, capacitación a padres y terapeutas, acondicionamiento de la planta física y acercamiento a la comunidad. Se realizó toma del índice inicial, actividades alusivas a la higiene bucal, toma de índice intermedio, refuerzo de actividades y posteriormente toma de índice final. Resultados: después de la implementación del nivel 0 de estimulación con niños con discapacidad, disminuyó el 33 por ciento del índice de higiene bucal; el nivel 1 disminuyó el 49 por ciento del índice de higiene oral; el nivel 2 disminuyó en un 56 por ciento; el nivel 3 disminuyó el 59 por ciento del índice de higiene oral, el nivel 4 disminuyó el 68 por ciento del índice de higiene oral y el nivel 5 disminuyó en un 70 por ciento del índice de higiene oral. Conclusión: programa de higiene oral donde se utilizaron estrategias tales como la musicoterapia y tableros de comunicación. La capacitación a padres y tutores favoreció la disminución del índice de higiene oral en niños y jóvenes con discapacidad cognitiva psicomotora y del lenguaje.


Sujets)
Humains , Mâle , Adolescent , Adulte , Enfant d'âge préscolaire , Enfant , Femelle , Soins dentaires pour personnes handicapées/méthodes , Éducation en santé dentaire , Plans et Programmes de Santé , Hygiène buccodentaire/enseignement et éducation , Brossage dentaire/méthodes , Musicothérapie/méthodes , Indice d'hygiène buccale , Interprétation statistique de données , Troubles psychomoteurs/thérapie , Troubles de la cognition/thérapie , Troubles du langage/thérapie
7.
Rev. Hosp. Clin. Univ. Chile ; 19(1): 5-14, 2008. tab, ilus
Article Dans Espagnol | LILACS | ID: lil-510427

Résumé

The stem cell transplantation (SCT) has improved the disease free survival of a great number of diseases. It began as an experimental procedure, used as last resource in terminally ill patients. Nowadays it is a proved tool that allow the patient receive high dose of chemoradiotherapy, without the bone marrow toxicity being a conditioning step. The haematological recovery follows the same mechanisms that the organisms have designed for this purpose. First, cryopreservation of progenitors stem cells (PSCs) is required, then these cells are re-infused into the blood. The PSCs find their own homing in the bone marrow, proliferate, differentiate and re establish the haematopoietic balance. The present revision gives some information about the different phase or a SCT, physiology background, indications and principals adverse effects.


Sujets)
Humains , Transplantation de cellules souches hématopoïétiques , Sélection de donneurs , Leucémies
9.
Rev. Hosp. Clin. Univ. Chile ; 17(2): 129-134, 2006. tab, ilus, graf
Article Dans Espagnol | LILACS | ID: lil-532932

Résumé

El trasplante alogénico de progenitores hematopoyéticos (TAPH) es una técnica que ha cambiado el pronóstico de muchas enfermedades hematológicas malignas y no malignas. En determinados tiempos post trasplante coexisten células hematológicas de receptor y dador, por lo cual el individuo posee dos sistemas hematopoyéticos. El término Quimera se utiliza para indicar el origen dual de las células hematológicas. Este análisis es indispensable para saber si existe prendimiento o rechazo del trasplante. La determinación de quimerismo se realiza mediante la amplificación por PCR de secuencias cortas repetidas tandem (STRs del ingles short tandem repeat sequence). Este examen es fácil de realizar, reproducible, altamente sensible y específico. El resultado del quimerismo es de vital importancia a la hora de tomar decisiones clínicas, sobre todo si se utilizan técnicas no mieloablativas de acondicionamiento, infusión de linfocitos del donante, o modificaciones en los protocolos de inmunosupresión, donde existe una lata variabilidad en el prendimiento del injerto y el desarrollo de enfermedad de injerto contra huésped (EICH) e injerto contra tumor (ICT).


Allogeneic progenitor cell transplantation (ALoPCT) is a procedure that has changed the prognosis of many malignant and non-malignant hematologic diseases. For a period of time post-trasplant, cellular subtypes from the donor and the host coexist, giving the patient two hematopoietic systems. The term Chimera is used to indicate the dual origin of blood cells. This analysis is important to determine whether engrafment or rejection has occurred. The determination of chimerism is based on PCR pf Short Tandem Repeat sequences (STRs). The PCR technique is easy to perform, reproducible, highly sensitive and specific. Chimerism determination helps to improve the clinical approach to the patient, specifically when non-mieloablative conditioning, lymphocyte donor infusion or modification of the immunosuppressive protocols have employed. All of these manipulations produce a high variability in engraftment, development of graft versus host disease (GVHD) and the likelihood to eliminate tumor cells through graft versus tumor (GVT) effects.


Sujets)
Humains , Mâle , Femelle , Chimérisme , Transplantation de cellules souches hématopoïétiques , Cellules souches hématopoïétiques , Transplantation homologue
10.
Rev. chil. infectol ; 22(4): 356-360, dic. 2005. ilus
Article Dans Espagnol | LILACS | ID: lil-427725

Résumé

Reportamos el primer caso de fusariosis diseminada en un paciente adulto en Chile, con una neoplasia hematológica y tratamiento quimioterápico, quien evolucionó con neutropenia febril prolongada, refractaria, fuera tratado con un amplio esquema antibacteriano y desarrollara una infección multisistémica, con compromiso cutáneo, sinusal y pulmonar por Fusarium oxysporum. Cursó con refractariedad al tratamiento antifúngico con anfotericina B deoxicolato y caspofungina, utilizados en forma secuencial. El desenlace fatal de este paciente se asoció a la persistencia de la neutropenia y a la infección por un hongo filamentoso habitualmente resistente a terapia antifúngica.


Sujets)
Mâle , Humains , Adulte d'âge moyen , Fusarium , Leucémie myéloïde/complications , Mycoses , Neutropénie/complications , Maladies de la peau/microbiologie , Issue fatale , Fièvre , Fongémie , Sujet immunodéprimé , Infections opportunistes/microbiologie , Défaillance multiviscérale/microbiologie
11.
Rev. méd. Chile ; 133(8): 887-893, ago. 2005. tab
Article Dans Espagnol | LILACS | ID: lil-429222

Résumé

Background:Multiple myeloma is rarely curable. Advances in high dose chemotherapy and stem cell transplantation have improved overall survival and event-free disease periods, but relapses are inevitable. Aim: To report our experience with AT in multiple myeloma, between 1994 and 2003. Material and Methods: Retrospective analysis of 20 patients (12 women), with a mean age of 51.1 years. VAD (vincristine, doxorubicin and dexamethasone) was used as initial therapy in 19 patients. High dose cyclophosphamide (11 patients) and variations of VAD regimen (7) associated with granulocyte colony stimulating factor were used for peripheral-blood stem cell harvest. The conditioning regimen consisted of melphalan 200 mg/m2 followed by the reinfusion of peripheral-blood stem cells 24 hours later. The median number of CD34 cells infused was 3,3x106/kg. Three patients were subjected to a second auto graft and one to a non-myeloablative transplant. Mean follow up was 35.5 months. Results: Mucositis and febrile neutropenia were common complications. The median number of days for neutrophyl engraftment was 9 (range 8-11) and for platelets, 10 (range 7-13). No patient died. Complete remission was obtained in 60% (12/20), progession-free survival was 30 months and overall median survival, 47 months. Conclusions: The AT with high-dose melphalan is a safe procedure in our hospital, without mortality and engraftment in all the patients. Complete remission and progression free survival were similar to those reported abroad but the overall median survival was lower.


Sujets)
Adulte , Femelle , Humains , Mâle , Adulte d'âge moyen , Myélome multiple/thérapie , Transplantation de cellules souches de sang périphérique , Conditionnement pour greffe , Antinéoplasiques/usage thérapeutique , Association thérapeutique , Survie sans rechute , Facteur de stimulation des colonies de granulocytes/usage thérapeutique , Études rétrospectives , Transplantation autologue , Résultat thérapeutique
12.
Rev. méd. Chile ; 132(11): 1403-1406, nov. 2004. ilus
Article Dans Espagnol | LILACS | ID: lil-391846

Résumé

We report a 78 year old male with prostatism, that was subjected to a prostate biopsy. The pathological study showed a microvascular lymphocytic infiltration. Four months later, the patients presentd with reduced alertness, cough, dyspnea, fever and elevation of lactic dehydrogenase and erythrocyte sedimentation rate. Chest and abdominal CAT scans, bone marrow aspirate, protein electrophoresis and prostate specific antigen were normal. A re-evaluation of prostate biopsy showed an intravascular lymphoid infiltration, positive for CD45 and CD20, compatible with the diagnosis of intravascular lymphoma. Chemotherapy was started, but it was not tolerated by the patient and the response was partial. Therefore, treatment with monoclonal antibodies anti CD20 (Rituximab) was started. The tumor had a complete and prolonged (24 months) remission after the treatment.


Sujets)
Humains , Mâle , Sujet âgé , Anticorps monoclonaux/usage thérapeutique , /usage thérapeutique , Antinéoplasiques/usage thérapeutique , Lymphome malin non hodgkinien/anatomopathologie , Tumeurs vasculaires/anatomopathologie , Biopsie , Endoscopie gastrointestinale , Hospitalisation , Lymphocytes TIL/anatomopathologie , Lymphome B/traitement médicamenteux , Lymphome B/anatomopathologie , Lymphome malin non hodgkinien/traitement médicamenteux , Tumeurs vasculaires/traitement médicamenteux
13.
Rev. Hosp. Clin. Univ. Chile ; 15(3): 209-212, 2004.
Article Dans Espagnol | LILACS | ID: lil-417150

Résumé

Los rodendicidas de uso doméstico están fácilmente disponibles en el comercio y, corresponden en general a superwarfarinas, cuyo mecanismo de acción es semejantea los anticoagulantes de uso clínico, pero difiere en una vida media más prolongada (meses) y una potencia cien veces mayor.Presentamos el caso clínico de una intoxicación con fines suicidas de Rodilon® (difethialone) 10 cajas de 50 g. La paciente ingresa con un tiempo de protrombina(TP) de 6 por ciento con un INR de 12.4, requiriendo administración de vitamina K1 durante varios meses. Las manifestaciones clínicas fueron leves (gingivorragia y petequias) al ingreso.En caso de no contar con el antecedente de ingesta, la intoxicación debe sospecharse en toda hipoprotrombinemia adquirida, sin antecedentes familiares de diátesis hemorrágica y, con función hepática normal.


Sujets)
Humains , Femelle , Adulte , Raticides , Raticides/effets indésirables , Raticides/intoxication , Raticides/toxicité , Warfarine/effets indésirables , Warfarine/intoxication , Warfarine/toxicité , Antidotes , Intoxication , Tentative de suicide
14.
Rev. méd. Chile ; 129(5): 547-51, mayo 2001. ilus
Article Dans Espagnol | LILACS | ID: lil-295257

Résumé

Background: Gastric Antral Vascular Ectasia or Watermelon stomach is a rare cause of chronic gastrointestinal bleeding, often presenting as a chronic iron deficiency anemia. This condition can be associated with some other diseases such as cirrhosis, autoimmune diseases and others. We report two patients treated with Argon Plasma Coagulation, a 68 years old male with an ethanol related cirrhosis and a 72 years old female with an idiopathic Gastric Antral Vascular Ectasia. The characteristic endoscopic features were mistaken for many years as gastritis. Both patients presented with severe anemia requiring multiple transfusions as treatment. Due to the poor operative risk, both patients were treated with Argon Plasma Coagulation with good results


Sujets)
Humains , Mâle , Femelle , Sujet âgé , Argon/usage thérapeutique , Ectasie vasculaire antrale/thérapie , Électrocoagulation/méthodes , Endoscopie gastrointestinale , Hémorragie gastro-intestinale/étiologie , Hémorragie gastro-intestinale/traitement médicamenteux , Ectasie vasculaire antrale/complications , Ectasie vasculaire antrale/diagnostic
16.
Rev. chil. infectol ; 12(4): 209-15, 1995. tab
Article Dans Espagnol | LILACS | ID: lil-174966

Résumé

Estudio prospectivo de 74 períodos consecutivos de neutropenia severa (menor o igual a 500 u/L) en 38 pacientes hematológicos del Hospital Clínico de la U. de Chile. La leucemia aguda constituye la principal enfermedad de base y la quimioterapia fue utilizada en el 81 por ciento de los episodios. En 60 períodos (81 por ciento) se logró demostrar infección y 51 de ellos (69 por ciento) cursaron febriles. Destacamos la presencia de 9 episodios de infección de curso afebril por constituir un hecho excepcional en estos pacientes. En los 60 períodos de neutropenia con infección se logró demostrar en el 80 por ciento uno o más focos, destacando el pulmonar, orofaríngeo, mucocutáneo y abdominal. El estudio microbiológico fue positivo en el 45 por ciento de los episodios febriles; se aislaron 34 microorganismos (bacilos Gram (-) 62 por ciento, cocáceas Gram (+) 26,3 por ciento, hongos 8,8 por ciento y virus 2,9 por ciento. Se constataron 11 bacteremias, todas por bacilos Gram (-) predominando K. pneumoniae y E. coli. El esquema ceftazidima-amikacina fue el más utilizado y se modificó en más del 50 por ciento de los casos (se asoció vancomicina, anfotericina B, u otro, o se reemplazó por imipenem, vancomicina y anfotericina B), con éxito terapéutico en el 75 por ciento de los casos. Se produjeron 17 fallecimientos, 13 de causa infecciosa. La mortalidad se asoció al diagnóstico de leucemia aguda, neutropenia prolongada, foco pulmonar y bacteremia por Gram (-). Los episodios febriles sin foco ni bacteriología se asociaron a buen pronóstico


Sujets)
Humains , Mâle , Femelle , Adolescent , Adulte , Adulte d'âge moyen , Infections bactériennes/étiologie , Association de médicaments , Neutropénie/complications , Amikacine/administration et posologie , Amikacine/usage thérapeutique , Infections bactériennes/traitement médicamenteux , Lymphome de Burkitt/traitement médicamenteux , Ceftazidime/administration et posologie , Ceftazidime/usage thérapeutique , Neutropénie/traitement médicamenteux , Neutropénie/microbiologie , Neutropénie/physiopathologie , Études prospectives
17.
Rev. méd. Chile ; 122(6): 694-8, jun. 1994. ilus
Article Dans Espagnol | LILACS | ID: lil-136209

Résumé

Clozapine is an atypical antipsychotic drug with a very low incidence of extrapyramidal effect, used in the treatment of schozophrenic patients refractory or intolerant to classical neuroleptics. Its use is limited due to the potential risk of producing agranulocytosis in 1 to 2 per cent of patients. Despite the severity of this complication, the Federal Drug Administration allowed its use as long as iots prescription is associated to a drug surveillance program. Two patients had a transitory leukopenia with less than 2000 leukocytes/ml and less than 1000 neutrophyls/ml, that reverted after discontinuing the drug. One patient, whose case is described, had a severe agranulocytosis with less than 500 neutrophyls/ml that required hospital admission


Sujets)
Humains , Mâle , Adulte , Clozapine/effets indésirables , Agranulocytose/induit chimiquement , Neutropénie/induit chimiquement , Schizophrénie/complications , Substances de croissance/administration et posologie , Systèmes de signalement des effets indésirables des médicaments/instrumentation
SÉLECTION CITATIONS
Détails de la recherche